drugset / Trial / NCT01883661
Safety and Efficacy of BMMNC in Multiple Sclerosis (MS)
NaSingle-groupOpen-labelTreatment
Summary
The aim of this study is to prove the BMMNC Therapy in Multiple sclerosis, and to control symptoms and help to maintain a normal quality of life of suffering patients.
Timeline
- Start
- 2014-06
- Primary completion
- 2016-11
- Completion
- 2016-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | BMMNC | Cell therapy | — | Intravenous |